Christele Perrin-East

Title: Innovations by Christele Perrin-East

Introduction

Christele Perrin-East is a notable inventor based in Marseille, France. She has made significant contributions to the field of biotechnology, particularly in the area of nucleoside reverse-transcriptase inhibition.

Latest Patents

Christele holds a patent for "Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment." This patent describes a transformed yeast cell that includes a nucleic acid sequence coding for a reverse transcriptase, a reverse transcription indicator, a nucleic acid sequence coding for deoxycytidine kinase (dCK), and at least one nucleic acid sequence coding for a nucleoside transporter. The patent also outlines methods for screening compounds that can inhibit reverse transcription and for predicting the sensitivity of a reverse transcriptase to a NRTI compound, particularly one derived from a virus infecting a subject using the transformed yeast cell.

Career Highlights

Christele is currently employed at Amikana Biologics, where she continues to advance her research and innovations in biotechnology. Her work focuses on developing methods that can enhance treatment options for viral infections.

Collaborations

One of her notable collaborators is Pablo Gluschankof, with whom she has worked closely on various projects related to her patent.

Conclusion

Christele Perrin-East's innovative work in biotechnology, particularly her patent on nucleoside reverse-transcriptase inhibition, showcases her commitment to improving treatment methodologies. Her contributions are significant in the ongoing fight against viral infections.